"10.1371_journal.pone.0011779","plos one","2010-07-26T00:00:00Z","John C Castle; Christopher D Armour; Martin LÃ¶wer; David Haynor; Matthew Biery; Heather Bouzek; Ronghua Chen; Stuart Jackson; Jason M Johnson; Carol A Rohl; Christopher K Raymond","Institute for Translational Oncology and Immunology, Mainz, Germany; Nugen Inc., Seattle, Washington, United States of America; University of Washington, Seattle, Washington, United States of America; Merck Research Laboratories, Boston, Massachusetts, United States of America; Rosetta Inpharmatics, Seattle, Washington, United States of America","Conceived and designed the experiments: JCC CDA JMJ CR CKR. Performed the experiments: JCC CDA MCB HKB. Analyzed the data: JCC CDA DRH RC. Contributed reagents/materials/analysis tools: JCC CDA ML SJ. Wrote the paper: JCC.","At the time of data acquisition, most authors were employed by Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co., Inc. Since 2009, authors have been employed by TRON, a not-for-profit translational oncology institute in Germany; by Nugen Inc.; by the University of Washington; and by Merck & Co. Rosetta/Merck paid employee salaries and funded the original research. Merck employees have reviewed the manuscript and approved the data release. Further analysis was done by JCC at TRON, a not-for-profit institute.","2010","07","John C Castle","JCC",11,TRUE,5,4,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
